156 related articles for article (PubMed ID: 4447892)
1. Serum calcium, phosphate and alkaline phosphatase and morphometric bone examinations in 30 patients with renal insufficiency.
Duursma SA; Visser WJ; Mees EJ; Njio L
Calcif Tissue Res; 1974; 16(2):129-38. PubMed ID: 4447892
[No Abstract] [Full Text] [Related]
2. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
Offermann G; Schaefer K; Schulz A; Delling G
Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
[TBL] [Abstract][Full Text] [Related]
3. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
Ahmed KY; Varghese Z; Meinhard EA; Baillod RA; Skinner RK; Wills MR; Moorhead JF
Adv Exp Med Biol; 1977; 81():581-90. PubMed ID: 899942
[No Abstract] [Full Text] [Related]
4. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
Malluche HH; Faugere MC; Fanti P; Price PA
Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
[TBL] [Abstract][Full Text] [Related]
5. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
Pierides AM; Ellis HA; Ward MK; Simpson W; Kerr DN
Calcif Tissue Res; 1977 May; 22 Suppl():105-11. PubMed ID: 912511
[No Abstract] [Full Text] [Related]
6. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
[No Abstract] [Full Text] [Related]
7. Hemodialysis bone disease: correlation between clinical, histologic, and other findings.
Alvarez-Ude F; Feest TG; Ward MK; Pierides AM; Ellis HA; Peart M; Simpson W; Weightman D; Kerr DN
Kidney Int; 1978 Jul; 14(1):68-73. PubMed ID: 682426
[TBL] [Abstract][Full Text] [Related]
8. Comparison of biochemical with radiological findings in renal osteodystrophy.
Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Wills MR
Ann Clin Biochem; 1975 May; 12(3):126-31. PubMed ID: 15637920
[TBL] [Abstract][Full Text] [Related]
9. Renal osteodystrophy in non-dialysed patients with chronic renal failure.
Andresen J; Nielsen HE
Acta Radiol Diagn (Stockh); 1980; 21(6):803-6. PubMed ID: 7234496
[TBL] [Abstract][Full Text] [Related]
10. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
Goulding A; McChesney R; Irvine RO; Dixon SR
N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274
[No Abstract] [Full Text] [Related]
11. Clinical problems of renal osteopathy in patients on hemofiltration.
Schulz W; Baier E; Hümpfner A; Delling G
Contrib Nephrol; 1982; 32():86-91. PubMed ID: 7128166
[No Abstract] [Full Text] [Related]
12. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
[No Abstract] [Full Text] [Related]
13. [Serum calcium, phosphorus and alkaline phosphatase as indicators in the therapy of renal osteodystrophy].
Labos I; Kovacević M
Med Arh; 1988; 42(4):181-5. PubMed ID: 3270761
[No Abstract] [Full Text] [Related]
14. Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
Winney RJ; Bone JM; Anderson TJ; Robson JS
Calcif Tissue Res; 1977 May; 22 Suppl():94-100. PubMed ID: 912593
[No Abstract] [Full Text] [Related]
15. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
[TBL] [Abstract][Full Text] [Related]
16. Plasma hydroxyproline in renal osteodystrophy.
Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
[No Abstract] [Full Text] [Related]
17. Total body calcium and long-term calcium balance in chronic renal disease.
Denney JD; Sherrard DJ; Nelp WB; Chesnut CH; Baylink DJ
J Lab Clin Med; 1973 Aug; 82(2):226-40. PubMed ID: 4721378
[No Abstract] [Full Text] [Related]
18. Serum bone gla-protein compared to bone histomorphometry in hemodialyzed patients.
Charhon SA; Delmas PD; Malaval L; Chavassieux PM; Chapuy MC; Meunier PJ
Adv Exp Med Biol; 1986; 208():291-6. PubMed ID: 3494387
[No Abstract] [Full Text] [Related]
19. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
[TBL] [Abstract][Full Text] [Related]
20. The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.
Junor BJ; Catto GR; Macleod M
Calcif Tissue Res; 1977 May; 22 Suppl():112-6. PubMed ID: 912512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
